Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 29, 2010
Controversies in the management of fever in the neutropenic cancer patientMatthew D Seftel
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 9, 2007
The role of hematopoietic stem cell transplantation in Chronic Lymphocytic LeukemiaVersha Banerji, James B Johnston, Matthew D Seftel
Current Oncology (Toronto, Ont.)|March 24, 2022
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in CanadaGraeme Ball, Christopher Lemieux, David Cameron, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2014
Potential consequences of essential drug shortages in Canada: Brain abscess due to Nocardia farcinica associated with dapsone prophylaxis for Pneumocystis jirovecii pneumoniaTerry C Wuerz, Eric J Bow, Matthew D Seftel
Transfusion|September 19, 2024
Recruiting blood donors to the Canadian Blood Services Stem Cell Registry: A feasibility assessmentGaganvir Parmar, Meagan Green, Kathy Ganz, et al.
Transfusion|March 24, 2023
Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groupsJohn T Blake, Gaganvir Parmar, Kathy Ganz, et al.
Transfusion|September 26, 2023
HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utilityAdrian J M Bailey, John Blake, Kathy Ganz, et al.
Internal Medicine (Tokyo, Japan)|August 7, 2007
Type I Gaucher disease following chemotherapy for light chain multiple myelomaWinson Y Cheung, Cheryl R Greenberg, Keevin Bernstein, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell TransplantationGaganvir Parmar, Matthew D Seftel, Kathy Ganz, et al.
Leukemia & Lymphoma|August 31, 2018
Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemiaCraig Speziali, Andrew Daly, Mohamed Abuhaleeqa, et al.
Pageof 5